Alcidion Appendix 4C – Quarter ending 31 December 2018 (Q2 FY2019)

Today Alcidion released its Appendix 4C quarterly cash flow report for the period ended 31 December. The quarter saw several significant material contracts signed with Queensland Health and ACT Health, with $14.3 million total contract value (TCV) added over the next five years. Currently, the company has $14.8 million to be recognised in FY19.

Net operating cash outflow for the quarter was $46K, inclusive of a one-off $40K final cost relating to the acquisition of MKM Health. This improved cash position relative to the previous corresponding period is reflective of the benefit of the expanded Alcidion Group.

View the Appendix 4C here.

A reminder that if you want keep in touch with Alcidion, click here to subscribe to our investor email distribution list and receive ASX announcements, news updates, newsletters and content exclusively for investors.